0001209191-23-026758.txt : 20230502 0001209191-23-026758.hdr.sgml : 20230502 20230502193427 ACCESSION NUMBER: 0001209191-23-026758 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230428 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Witz Pascale CENTRAL INDEX KEY: 0001703723 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 23881182 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-28 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001703723 Witz Pascale C/O HORIZON THERAPEUTICS PLC, 70 ST. STEPHEN?S GREEN DUBLIN L2 D02 E2X4 IRELAND 1 0 0 0 0 Ordinary Shares 2023-04-28 4 M 0 3913 A 18202 D Ordinary Shares 2023-04-28 4 F 0 1879 111.16 D 16323 D Ordinary Shares 29628 I By Trust Restricted Stock Units 2023-04-28 4 M 0 3913 0.00 D 2023-04-28 2023-04-28 Ordinary Shares 3913 0 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 14,289 Ordinary Shares previously reported as indirectly held by Trust held directly. /s/ Meghanne Downes, Attorney-in-Fact 2023-05-02